#Blood_Cancer
Impact of Immunotherapy on Blood Cancer Treatment: Upcoming Lecture in Tokyo#Japan#Immunotherapy#Tokyo#Blood_Cancer#Tokyo_Medical_Institute
Impact of Immunotherapy on Blood Cancer Treatment: Upcoming Lecture in Tokyo
On May 23, 2026, a lecture on innovative blood cancer treatments using immunotherapy will be held in Tokyo. Join us for insights!
third-news.com
March 26, 2026 at 6:21 AM
HealthTree Foundation Unveils Leif: A Smart AI Assistant for Blood Cancer Patients#USA#Salt_Lake_City#Blood_Cancer#HealthTree_Foundation#Leif
HealthTree Foundation Unveils Leif: A Smart AI Assistant for Blood Cancer Patients
HealthTree Foundation has introduced Leif, an AI assistant aimed at assisting blood cancer patients in accessing critical information quickly and efficiently.
third-news.com
March 18, 2025 at 10:33 PM
Alexandria Real Estate Equities: Driving Innovation in Blood Cancer Solutions with Strategic Partnerships and Philanthropy#USA#Pasadena#Blood_Cancer#Alexandria_Real_Estate#Juno_Therapeutics
Alexandria Real Estate Equities: Driving Innovation in Blood Cancer Solutions with Strategic Partnerships and Philanthropy
Alexandria Real Estate Equities showcases its commitment to blood cancer research and philanthropy, driving innovation and partnerships to improve patient outcomes.
third-news.com
September 4, 2026 at 12:43 PM
AbbVie Unveils Promising Blood Cancer Research at EHA 2026 Congress#USA#Blood_Cancer#Epcoritamab#AbbVie#North_Chicago
AbbVie Unveils Promising Blood Cancer Research at EHA 2026 Congress
AbbVie showcased groundbreaking data on multiple blood cancers at EHA 2026, underscoring their commitment to improving cancer treatment outcomes.
third-news.com
June 8, 2026 at 12:37 PM
AbbVie Showcases Breakthrough Blood Cancer Research at EHA 2026 Congress#USA#Blood_Cancer#AbbVie#North_Chicago#EHA_2026
AbbVie Showcases Breakthrough Blood Cancer Research at EHA 2026 Congress
AbbVie highlights innovative advancements in blood cancer treatments, presenting vital data at EHA 2026, enhancing patient care and treatment options.
third-news.com
June 8, 2026 at 12:18 PM
Growth Forecast for Hematology Analyzers and Reagents Market Expected to Reach $10.33 Billion by 2031#USA#Delray_Beach#Hematology#diagnostics#Blood_Cancer
Growth Forecast for Hematology Analyzers and Reagents Market Expected to Reach $10.33 Billion by 2031
The Hematology Analyzers and Reagents Market is set to grow significantly from $7.57 billion in 2026 to $10.33 billion by 2031, marking a major trend in diagnostics.
third-news.com
May 13, 2026 at 12:06 PM
Dee and Jimmy Haslam Contribute $12.5 Million to Combat Blood Cancer at University Hospitals#USA#Cleveland#Blood_Cancer#University_Hospitals#Haslam_Investment
Dee and Jimmy Haslam Contribute $12.5 Million to Combat Blood Cancer at University Hospitals
Dee and Jimmy Haslam have pledged $12.5 million to University Hospitals to advance blood cancer research, particularly focusing on chronic lymphocytic leukemia.
third-news.com
May 6, 2026 at 4:09 PM
New Therapeutic Approaches Offer Hope in Blood Cancer Treatments Without Chemotherapy#USA#Orlando#Immunotherapy#Blood_Cancer#Targeted_Therapy
New Therapeutic Approaches Offer Hope in Blood Cancer Treatments Without Chemotherapy
Recent studies highlight the potential of targeted therapies and immunotherapies in replacing traditional chemotherapy for blood cancers, promising improved patient outcomes.
third-news.com
December 7, 2025 at 12:32 PM
Technological Innovations Transform Blood Cancer Therapies to Enhance Patient Outcomes#USA#Orlando#Clinical_Trials#ASH_Meeting#Blood_Cancer
Technological Innovations Transform Blood Cancer Therapies to Enhance Patient Outcomes
Recent advancements in blood cancer therapies shown in clinical trials demonstrate better safety and accessibility for patients, heralding a new era in treatment.
third-news.com
December 6, 2025 at 1:37 PM
Innovative Blood Cancer Research to be Unveiled by Rutgers Cancer Institute at ASH Annual Meeting 2025#USA#Orlando#Rutgers_Cancer_Institute#Blood_Cancer#ASH_2025
Innovative Blood Cancer Research to be Unveiled by Rutgers Cancer Institute at ASH Annual Meeting 2025
Rutgers Cancer Institute and RWJBarnabas Health will present groundbreaking blood cancer research at the 67th ASH Annual Meeting in Florida.
third-news.com
December 2, 2025 at 1:38 PM
Jeff Bridges Shares His Journey of Hope and Recovery in Blood Cancer Campaign#USA#New_York#Jeff_Bridges#Blood_Cancer#Lymphoma
Jeff Bridges Shares His Journey of Hope and Recovery in Blood Cancer Campaign
Actor Jeff Bridges opens up about his personal battle with lymphoma as part of the Blood Cancers & Disorders campaign, emphasizing hope and resilience.
third-news.com
September 12, 2025 at 11:36 AM